Matthew Karlyn

Represented LIVEKINDLY Collective, a collection of heritage and start-up brands on track to become one of the world's largest plant-based food companies, on the commercial and intellectual property aspects of its establishment, together with RCL Foods, of a plant-based joint venture, LIVEKINDLY Collective Africa.

Represent Adagene, a clinical stage biotech company, in a material transfer and research relationship associated with Adagene’s proprietary materials, with a major university.

Represented Vizgen in a university licensing transaction to support Vizgen’s gene profiling instrumentation and data analysis, with a major university.

Represented CareDx, a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, in licensing and research collaboration agreements with a major university, and in a material transfer agreement to support a feasibility study with CRISPR Therapeutics.

Represented clients in licensing and other commercial life sciences transactions adverse to a number of universities including Harvard, MIT, Cornell, Stanford, University of California-San Diego, University of California-Berkeley, University of Pittsburgh, University of Michigan, Tufts, and Northeastern.

Represented BluesphereBio in all licensing matters, including pending deals with a major university and the university's medical center.